Delayed diagnosis of HIV infection in women in the Auckland and Northland regions.

N Z Med J

Infectious Disease Physician, Infectious Disease Unit, Auckland City Hospital, Auckland.

Published: June 2022

Aims: We aimed to describe the epidemiology of women with HIV infection in the Auckland and Northland regions, and to assess whether there were missed opportunities for an earlier diagnosis of HIV infection.

Methods: We undertook a retrospective cohort analysis of women diagnosed with HIV infection between July 2011 and June 2021 under the care of the Infectious Disease Unit, Auckland City Hospital.

Results: Fifty-six women (54 cis and 2 trans) were diagnosed during the period. Eleven (20%) were diagnosed following a presentation with one or more AIDS-defining illnesses. Three (6%) died within six months of diagnosis. Fifteen of 44 (34%) women residing in New Zealand prior to their diagnosis of HIV infection had identifiable healthcare interactions that could have resulted in an earlier diagnosis of this infection.

Conclusions: Women account for one in eight of the total population of people diagnosed with HIV infection in the Auckland and Northland regions. There are currently inadequate levels of HIV testing for women in the Auckland and Northland regions. There is a need for targeted HIV screening efforts for women. HIV screening needs to be optimised to maximise coverage, normalise testing and reduce the stigmatisation associated with testing.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hiv infection
20
auckland northland
16
northland regions
16
diagnosis hiv
12
hiv
9
women
8
women auckland
8
women hiv
8
infection auckland
8
earlier diagnosis
8

Similar Publications

Herpes simplex virus (HSV) infection is one of the most prevalent viral infections worldwide. In general, host immunity is sufficient to clear viral shedding and recurrences, although it is insufficient to prevent subsequent virologic reactivations. In immunocompromised patients, prolonged and difficult-to-treat HSV infections may develop.

View Article and Find Full Text PDF

Introduction: HIV self-testing (HIVST) is an innovative strategy that has been shown to increase uptake of HIV testing compared to conventional facility-based testing. HIVST implementation with digital-based supports may help facilitate testing accessibility and linkage to care after a reactive self-test. Economic evidence around community-based implementation of HIVST is growing; however, economic evidence around digital-based HIVST approaches remains limited.

View Article and Find Full Text PDF

Background: Infection with the human immunodeficiency virus and hepatitis viruses B and C have been reported to be endemic in some Nigeria's institutions of higher learning. Several studies have reported varying prevalence rates for hepatitis B and C viruses and HIV among undergraduate students in Nigerian universities.

Methodology: A cross-sectional descriptive prevalence study of hepatitis B and C viruses and HIV among students at Federal University of Health Sciences, Azare conducted on the 2nd of December 2023.

View Article and Find Full Text PDF

Background: People living with HIV (PWH) frequently have co-morbid substance use disorders that may have been impacted by the COVID-19 pandemic. This study examined associations between COVID-related stress and increased substance use among PWH in Washington State.

Methods: Between August 2020 and March 2021, we conducted an online survey of 397 PWH in Western Washington.

View Article and Find Full Text PDF

Objectives: Advanced HIV disease (AHD) at HIV care enrollment is common in Latin America and may bias cross-sectional care continuum estimates. We therefore explored the impact of AHD on HIV care continuum outcomes using a longitudinal approach.

Methods: We analyzed trajectories of 26,174 adult people with HIV enrolled at Caribbean, Central and South America network for HIV epidemiology (CCASAnet) sites (2003-2019) using multi-state Cox regression across five stages: (i) enrolled without antiretroviral therapy (no-ART); (ii) on ART without viral suppression (viral load ≥200 copies/m; ART + non-VS); (iii) on ART with viral suppression (viral load <200 copies/ml; ART + VS); (iv) lost to follow-up; (v) death.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!